We Just Asked FDA for the Meeting That Unlocks Phase 3 | Sen-Jam Pharmaceutical

https://wefunder.com/feed/306614

Published at: 2026-04-23 14:10:31 UTC

Author: Jim Iversen

Subject: Sen-Jam Pharmaceutical

Dear Sen-Jam Investors & Community, On April 22, 2026, Sen-Jam Pharmaceutical submitted an End-of-Phase 2 meeting request to the U.S. Food and Drug Administration for SJP-001, our lead program. This is the regulatory hinge between completed ea...